Rakuten Securities’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.2K Buy
65
+18
+38% +$2.7K ﹤0.01% 461
2026
Q1
$7.18K Sell
47
-222
-83% -$34K ﹤0.01% 468
2025
Q4
$37.1K Sell
269
-721
-73% -$94.4K 0.01% 271
2025
Q3
$127K Buy
990
+984
+16,400% +$120K 0.05% 170
2025
Q2
$726 Sell
6
-10
-63% -$1.13K ﹤0.01% 693
2025
Q1
$1.78K Buy
16
+1
+7% +$106 ﹤0.01% 608
2024
Q4
$1.46K Buy
15
+10
+200% +$1.07K ﹤0.01% 592
2024
Q3
$575 Sell
5
-85
-94% -$9.64K ﹤0.01% 627
2024
Q2
$9.58K Sell
90
-11
-11% -$1.1K ﹤0.01% 336
2024
Q1
$9.77K Buy
101
+83
+461% +$8.51K ﹤0.01% 331
2023
Q4
$1.82K Buy
+18
New +$1.74K ﹤0.01% 431

Other funds holding NVS

Rakuten Securities's NVS Position: Q2 2026 in Review

Rakuten Securities increased its Novartis (NVS) stake by 38% in Q2 2026, buying an estimated $2.7K and bringing the position to 65 shares worth $10.2K. The position accounts for ﹤0.01% of the portfolio, ranked #461.

Rakuten Securities first reported a position in NVS in Q4 2023 and has held it in 11 quarters since. The position peaked at $127K in Q3 2025. 1,611 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Rakuten Securities held 65 shares of Novartis worth $10.2K as of Q2 2026.
  • Rakuten Securities bought 18 Novartis shares in Q2 2026, an estimated $2.7K.
  • Novartis made up ﹤0.01% of Rakuten Securities's portfolio in Q2 2026, its #461 holding.
  • Rakuten Securities first reported a position in Novartis in Q4 2023 and has held it in 11 quarters since.
  • Rakuten Securities's Novartis position peaked at $127K in Q3 2025.
  • 1,611 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Rakuten Securities's 13F filing for Q2 2026, filed 12 Aug 2026.